Total Pancreatectomy (R0 Resection) Improves Survival over Subtotal Pancreatectomy in Isolated Neck Margin Positive Pancreatic Adenocarcinoma
Overview
Authors
Affiliations
Unlabelled: In patients undergoing pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC), conversion to total pancreatectomy (TP) may be necessary to achieve R0 resection.
Hypothesis: We sought to examine the oncologic benefit of conversion of PD to TP to achieve an R0 resection in patients with an isolated positive neck margin.
Methods: We conducted a retrospective analysis of prospectively collected data at Indiana University and Johns Hopkins Medical Institutions. A review of 1,579 patients who underwent PD or TP for PC at these institutions between 1992 and 2006 was performed. Sixty-one patients were eligible.
Results: Twenty-eight patients underwent PD with an isolated positive neck margin found on pathologic examination; 33 patients had conversion to TP for isolated neck margin involvement to achieve R0 resection. Patients undergoing TP versus PD had a greater median survival (18 vs 10 months; P = .04). Mortality (6% vs 7%) and morbidity (36% vs 54%; P = .20) for TP versus PD were comparable. Multivariate analysis revealed PD and greater tumor size as the only independent predictors of poor long-term survival (hazard ratio [HR], 2.2; P = .01 and HR, 1.3; P = .005).
Conclusions: Conversion of PD to TP to achieve an R0 resection in patients with pancreatic adenocarcinoma is associated with a survival benefit.
Positive pancreatic neck margins-a telltale sign of complex biology.
Ghabi E, He J Hepatobiliary Surg Nutr. 2022; 11(2):302-304.
PMID: 35464273 PMC: 9023820. DOI: 10.21037/hbsn-21-553.
Pancreatic cancer in 2021: What you need to know to win.
Tonini V, Zanni M World J Gastroenterol. 2021; 27(35):5851-5889.
PMID: 34629806 PMC: 8475010. DOI: 10.3748/wjg.v27.i35.5851.
Crippa S, Belfiori G, Tamburrino D, Partelli S, Falconi M Updates Surg. 2021; 73(4):1219-1229.
PMID: 34331677 DOI: 10.1007/s13304-021-01141-0.
Inoue Y, Oba A, Ono Y, Sato T, Ito H, Takahashi Y Cancers (Basel). 2021; 13(8).
PMID: 33920314 PMC: 8068970. DOI: 10.3390/cancers13081818.
You L, Yao L, Mao Y, Zou C, Jin C, Fu D World J Gastrointest Surg. 2021; 12(12):491-506.
PMID: 33437401 PMC: 7769744. DOI: 10.4240/wjgs.v12.i12.491.